The Maddrey score is also called the Maddrey discriminant function, MDF, mDF, DFI or just DF. It’s one of several tools or calculations doctors. The Maddrey Discriminant Function is a calculation for patients with alcoholic hepatitis and stratifies them for risk of mortality and the use of steroids. Formula. BACKGROUND/AIMS: Maddrey discriminant function (DF) is the traditional model for evaluating the severity and prognosis in alcoholic hepatitis (AH). However.
|Published (Last):||2 January 2014|
|PDF File Size:||6.31 Mb|
|ePub File Size:||6.33 Mb|
|Price:||Free* [*Free Regsitration Required]|
Discriminant Function (Alcoholic Hepatitis) | Calculate by QxMD
Enter your email address and we’ll send you a link to reset your password. Please fill out required fields.
Maddrey has authored numerous publications based on research interests in chronic viral hepatitis, drug-induced liver disease, alcohol-induced liver disease, liver transplantation, and primary biliary cirrhosis.
Willis Maddrey’s publications, visit PubMed. Calc Function Calcs that help predict probability of a disease Diagnosis. Subcategory of ‘Diagnosis’ designed to be very sensitive Rule Out. Numerical inputs and outputs Formula. Med treatment and more Treatment.
Or create a new account it’s free. To save favorites, you must log in.
Creating an account is free, easy, and takes about 60 seconds. Log In Create Account. The principal investigators of the study request that you use the official version of the modified score here.
Maddrey’s Discriminant Function for Discfiminant Hepatitis Suggests which patients with alcoholic hepatitis may have a poor prognosis and benefit from steroid administration. Maddrey’s Discriminant Function is useful in predicting short-term prognosis but is less useful for long-term prognosis.
Advice Scores above 32 typically suggest poor prognosis and that these patients may be helped by steroid administration.
Maddrey Discriminant Score – GIHEP
Corticosteroid therapy of alcoholic hepatitis. Validation Soultati AS, et. Predicting utility of a model for end stage liver disease in alcoholic liver disease. World J Gastroenterol July 07;12 About the Creator Dr.